Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Zeitschrift Fur Kardiologie
|
March 1, 1979
[Hemodynamics in patients suffering from hyperkinetic cardiac syndromes and in normal persons under psychological stress before and after treatment with propranolol (author's transl)]
D Magometschnigg, J Bonelli, G Kaik
Climacteric : the Journal of the International Menopause Society
|
May 7, 2010
Hypertension in women: the role of progesterone and aldosterone
E Boschitsch, S Mayerhofer, D Magometschnigg
International Journal of Clinical Pharmacology and Biopharmacy
|
January 1, 1978
The acute bronchodilator effect of subcutaneously injected drugs. A comparison between atropine, adrenaline, orciprenaline, and terbutaline
G Kaik, J Bonelli, D Magometschnigg
European Journal of Clinical Pharmacology
|
January 1, 1984
Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man
D Magometschnigg, H Hörtnagl, H Rameis
Cardiology
|
January 1, 1982
Hyperkinetic heart syndrome: the role of the sympathetic nervous system
H Hörtnagl, D Magometschnigg, J Prager
Pharmazie in Unserer Zeit
|
August 14, 2001
[Measurement precision and correctness!? Blood pressure measuring instrument critical assessing]
D Magometschnigg, N Mair, G Hitzenberger
International Journal of Clinical Pharmacology and Biopharmacy
|
November 1, 1979
Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol
D Magometschnigg, J Bonelli, G Kaik
Clinical Pharmacology and Therapeutics
|
August 1, 1984
The diltiazem-digoxin interaction
H Rameis, D Magometschnigg, U Ganzinger
Wiener Medizinische Wochenschrift (1946)
|
January 1, 1977
[Inhalation or peroral therapy with bronchospasmolytics]
G Kaik, J Bonelli, D Magometschnigg
Calcified Tissue International
|
March 1, 1995
A comparative bioavailability study on two new sustained-release formulations of disodiummonofluorophosphate versus a nonsustained-release formulation in healthy volunteers
L Erlacher, H Templ, D Magometschnigg
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Zeitschrift Fur Kardiologie
|
March 1, 1979
[Hemodynamics in patients suffering from hyperkinetic cardiac syndromes and in normal persons under psychological stress before and after treatment with propranolol (author's transl)]
D Magometschnigg, J Bonelli, G Kaik
Climacteric : the Journal of the International Menopause Society
|
May 7, 2010
Hypertension in women: the role of progesterone and aldosterone
E Boschitsch, S Mayerhofer, D Magometschnigg
International Journal of Clinical Pharmacology and Biopharmacy
|
January 1, 1978
The acute bronchodilator effect of subcutaneously injected drugs. A comparison between atropine, adrenaline, orciprenaline, and terbutaline
G Kaik, J Bonelli, D Magometschnigg
European Journal of Clinical Pharmacology
|
January 1, 1984
Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man
D Magometschnigg, H Hörtnagl, H Rameis
Cardiology
|
January 1, 1982
Hyperkinetic heart syndrome: the role of the sympathetic nervous system
H Hörtnagl, D Magometschnigg, J Prager
Pharmazie in Unserer Zeit
|
August 14, 2001
[Measurement precision and correctness!? Blood pressure measuring instrument critical assessing]
D Magometschnigg, N Mair, G Hitzenberger
International Journal of Clinical Pharmacology and Biopharmacy
|
November 1, 1979
Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol
D Magometschnigg, J Bonelli, G Kaik
Clinical Pharmacology and Therapeutics
|
August 1, 1984
The diltiazem-digoxin interaction
H Rameis, D Magometschnigg, U Ganzinger
Wiener Medizinische Wochenschrift (1946)
|
January 1, 1977
[Inhalation or peroral therapy with bronchospasmolytics]
G Kaik, J Bonelli, D Magometschnigg
Calcified Tissue International
|
March 1, 1995
A comparative bioavailability study on two new sustained-release formulations of disodiummonofluorophosphate versus a nonsustained-release formulation in healthy volunteers
L Erlacher, H Templ, D Magometschnigg
Page
of 8